In the course of our efforts to discover novel antifungal agents, we found that cultivation of a strain of the Hyphomycete Dictyochaeta simplex produces a new /M,3-D-glucan synthesis inhibitor, L-687,781. /M,3-D-Glucan synthesis recently has been identified as an effective target for combatting Pneumocystis carinii pneumonia (PCP)1}. PCP is a common opportunistic infection in AIDS patients which is frequently life threatening. The structure of L-687,781 was determined to be 1, a new memberof the papulacandin family ofantibiotics2'3).
Described in this paper are the production, isolation, and some biological properties of L-687,781. The structure elucidation of L-687,781 will be described elsewhere40. Conidiophores and conidia on malt extract agar (standard bar = 10 pirn). dark greenish olive, dark olive, dark grayish olive, olivaceous black, mineral gray, smoke gray.
Results

Identification
Mycelium slightly immersed in the agar, septate, branched, with hyphae 1~5/zm wide, hyaline to gray brown or olive gray in KOH.Setae absent. Conidiophores arising directly from the vegetative mycelium, macronematous or mononematous, 23~140 x 3~5/mi, simple or rarely branched, straight to slightly flexuous, 0~4 septate, cylindrical or sometimes tapered at point of attachment to vegetative mycelium, sometimes inflated towards apex, often with successive proliferations, thin-walled to slightly thick-walled, hyaline to pale olive brown in KOH.Conidiogenous cells phialidic, integrated, with terminal or lateral collarettes. Collarettes shallowly cylindrical to nearly hemispherical, up to 4/xm wide x 2.5/^m deep, thin-walled, hyaline. Conidia 13~19.5 x 3~4.5 /mi, with two setulae, narrowly crescent-shaped to fusiform with, smooth-walled, aseptate, with finely granular cytoplasm, hyaline to pale grayish yellow in KOH. Setulae at distal ends of conidia, straight to slightly curved, hyaline, 3~6//m long. Fermentation The average time course of L-687,781 production by D. simplex grown in 70-liter fermenters is shown in Fig. 2 . As is typical with fungi, cell growth continued through 5 days, as evidenced by an increase in packed cell volume until a maximumof 15~17%was attained. The pH of the culture broth decreased gradually over the course of the fermentation. Production of L-687,781 was first determined at 108 hours, 
Antifungal Activity
As shown in Table 1 , L-687,781 is a potent antifungal agent against various Candida spp. in vitro. As was observed for other members of the papulacandin family2*, L-687,781 is inactive against bacteria, filamentous fungi (data not shown) and MICvalues (/ig/ml) were determined using broth (yeast nitrogen base glucose) microdilution assay.
Cryptococcus neoformans (Table 1 ). In general the MIC values for L-687,781 are comparable to those observed for amphotericin B and are lower than those observed for 5-fluorocytosine and ketoconazole. The echinocandin /M,3-D-glucan synthesis inhibitor L-671,329, recently isolated in these labs9>10), shows comparable MICvalues with those observed for L-687,781. Due to the potent in vitro activity exhibited by L-687,781, an in vivo efficacy study was undertaken. In this study mice were systemically challenged (iv) with C. albicans MY1055and treated (ip) with L-687,781 (twice-daily). Four days after challenge the mice were sacrificed and the number of viable C. albicans colonies recovered from the mousekidneys was determined. Despite the potent in vitro activity, treatment with L-687,781 in this in vivo model up to lO mg/kg body weight produced no significant efficacy compared to infected DMSOsham-treated control mice. Table 2 show that doses of L-687,781 which are ineffective for treating C. albicans infections in mice (vide supra), were statistically effective in reducing P. carinii cysts in rats. The total number of cysts per animal lung is expressed as the mean log10 ( + the standard error of the geometric mean, SEM). The lower limit of detection was 2 x 104 cysts per lung (Iog10=4.26). a Significantly different from their corresponding controls (P<0.05, Student's t-test). Complete seed medium was dispensed 50ml into 250-ml Erlenmeyer flasks or 500ml into 2-liter Erlenmeyer flasks and sterilized at 121°C, 1.05 kg/cm2 for 20 minutes. Culture development was always begun by inoculating 2.0ml from an FVMinto 50ml seed medium and incubating at 26°C, 220rpm, 85% humidity for 72 hours. The resultant culture was aseptically transferred (2% inoculum) to the same seed medium in 2-liter Erlenmeyer flasks and incubated at 26°C, 180 rpm, 85% humidity for 48 hours. Two 70-liter Chemap fermenters were charged with 50 liters production medium which consisted of (in g/liter): Cerelose 55.0, glycerol 10.0, glycine 2.0, lard water 5.0, soybean meal 5.0, sodium citrate 2.0, KH2PO4 2.0, CoCl2 -6H2O 0.01 and P-2000 (antifoam), 2.0 ml/liter; medium pH was adjusted to 7.0 and sterilized at 122°C, 1.05 kg/cm2 for 25 minutes. The resultant culture was transferred (4% inoculum) to each of the previously prepared fermenters. Fermentations proceeded at 26°C for 192 hours with an air flow of 15 liters per minute and an agitation rate of 400 rpm.
Isolation of L-687,781 Biological activity was followed during the course of the isolation by agar disk diffusion assay versus Candida pseudotropicalis MY1 1 00.
The mycelia from the above 100-liter fermentation were separated from the broth using a Sharpies Hexane (4 liters) was added to the MeOH-H2O extract, the layers were separated. A saturated NaCl solution (4 liters) was added to the resulting aqueous methanol layer and the L-687,781 was extracted into CH2C12(3 x 6 liters). The CH2C12extracts were combined, dried over anhydrous Na2SO4, and concentrated to a tar {ca. 80g).
The residue was dissolved in MeOH, adsorbed onto silica gel (400g), and the MeOH was removed in vacuo. The residue coated silica gel was then applied to a silica gel chromatography column (1.5 liters of Silica gel 60, 0.040~0.063mm) packed in CH2C12. The column was eluted with CH2C12containing increasing amounts of MeOH.L-687,781 was obtained in the MeOH-CH2Cl2(10:90) eluate. These fractions were combined and concentrated to yield 6.2g of a black solid.
This rich cut was dissolved in MeOH(20ml) and added (with some precipitation) to 50mMpotassium phosphate pH 6.5 buffer (40ml) at the head of a reverse phase flash chromatography column (50ml of Baker octadecyl, 0.040mm). The column was eluted with 50mMpotassium phosphate pH 6.5 buffer containing increasing amounts of MeOH.The L-687,781 was obtained between the 60% and the 70% MeOHfractions. The L-687,781 containing fractions were combined and concentrated to yield 3.1 g of a tansolid.
A portion (39mg) of the above solid was reconstituted in 2ml of46 : 54, acetonitrile -H2Oand applied to a preparative HPLC column (Whatman Magnum 20 C18, 22mmi.d. x25cm, 10ml/minute, 46: 54, acetonitrile-H2O). The fractions eluting between 32 and 39 minutes were combined and the solvents removed in vacuo to yield 23mg of pure L-687,781 as a white solid: MP168~173°C (with dec). The UV spectrum (MeOH) of L-687,781 exhibited Amaxnm (E1%) at 262 (330), 240 (260), and a shoulder at 230 (240). FAB-MS indicated a MWof 902 (observed (M+H) at m/z 903)4). /M,3-D-Glucan Synthesis Inhibition Assay Protoplasts of C. albicans MY1208were prepared as described by Taft et al.12 ) with the following modifications: 1.2m glycerol was substituted for 1.2m sorbitol and the protoplasts were washed three additional times after Novozyme 234 treatment. Aliquots (1 ml) of washed protoplasts were stored in 1.2 m JAN. 1991 glycerol-PBS containing 0.5 niM phenylmethyl sulfonyl fluoride (PMSF) and 1 niM dithiothreitol (DTT) at -80°C. The glucan synthase system was prepared prior to use by sonication, centrifugation (100,000 x g, 30 minutes), and resuspension in the storage buffer. /M,3-D-Glucan synthesis was measured by an assay similar to that described by Cabib and Kang for Saccharomyces cerevisiae1 3). Each reaction vessel contained a total of 80^1 consisting of the following: 4 /il of L-687,781 dissolved in DMSOat various concentrations, 15^1 of the above protoplast suspension, 5 /d of UDP-[*7-14C]glucose (348 mCi/mmol), a-amylase (4units), Tris-HCl (pH 7.5) 125mM, DTT 0.25him, PMSF0.15mM, glycerol 0.40m, EDTA0.75mM, bovine serum albumin 1.0%, guanosine 5'-<9-(3-thiotriphosphate) tetralithium salt 40nM, and laminaribiose 4.0mM. After incubation for 60 minutes at room temperature, the reactions were stopped by addition of 10%TCA(1 ml). The solutions then were cooled in an ice bath for 15 minutes and filtered. The filtrates were washed with TCA(four times) and ethanol (twice), added to scintillation liquid (10 ml of Aquasol-2), and the radioactivity was measured.
Acute Rat Model P. carinii Pneumonia and Evaluation of Infected Lung Tissues The P. carinii pneumonia rat model used in this study1} is a modification of those originally described by Frenkel et al.14) and by Hughes et al.15 immunosuppressed with dexamethasone in the drinking water (2 mg/liter) to induce P. carinii pneumonia. Tetracycline (1 g/liter) also was added to the drinking water to prevent bacterial infections. After 6 weeks of immunosuppression three rats were selected randomlyand sacrificed to confirm the presence of P.
carinii pneumonia.The remaining rats weredistributed into groups of 5~6 and injected ip twice-daily for 4 days with 0.5ml of various concentrations of L-687,781 in vehicle (10% DMSO)or vehicle alone. At the completion of treatment all rats were sacrificed by exposure to carbon dioxide gas, the lungs were removed and homogenized with a Brinkmann homogenizer in 10.0ml of saline solution. The lung homogenates were centrifuged (1,000 x g) and the supernatant discarded. The pellet was resuspended in 5.0ml of 0.85% ammoniumchloride solution and incubated for 5 minutes at 37°C to lyse the red cells. The solution was centrifuged (1,000 x g) and the resulting pellet was washed two additional times by alternate addition of saline and centrifugation. The final pellet was resuspended in 2.0 ml of saline. A 5.0-/il aliquot was taken from each sample and dried onto teflon coated microscope slides with a fixed surface area (1 1 mmcircles) .
The total number of cysts per animal lung was determined by counting the number of cysts per 50 microscope fields (1,000 x ) of homogenized lung tissue on slides fixed with ether-sulfuric acid and stained with toluidine blue16). The total number of organisms per rat lung was determined as a function of the surface area on the slide, the volume of the applied sample and the total volume of the processed homogenate. 
